Australian and New Zealand Massive Transfusion Registry

Launched by MONASH UNIVERSITY · Aug 7, 2016

Keywords

ClinConnect Summary

The Australian and New Zealand Massive Transfusion Registry (MTR) is studying how to better manage and treat patients who experience severe blood loss due to various medical situations, such as serious injuries, childbirth, or major surgeries. This registry collects important information about these patients, specifically those who receive five or more units of red blood cells in a short time frame. By analyzing this data, researchers hope to learn more about the causes of critical bleeding, the effectiveness of different treatment methods, and what happens to patients after they receive massive transfusions.

To participate in this study, individuals must be 18 years or older and have received a significant amount of blood (five or more units) within a four-hour period. There are no specific conditions that would exclude someone from joining the trial. Participants can expect their medical data to be collected and used to help improve treatment strategies for future patients experiencing similar issues. This registry aims to become a valuable resource for healthcare providers and researchers in understanding and improving care for those with serious bleeding.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • aged 18 years or over
• • 5 or more units of red blood cells in any 4 hour period
• Exclusion Criteria:
• • nil